Virologic outcomes of complex drug regimens for human immunodeficiency virus

JAMA. 2002 Nov 20;288(19):2405-6; author reply 2406.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Benzoxazines
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Oxazines / therapeutic use
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Treatment Failure
  • Viral Load*

Substances

  • Anti-HIV Agents
  • Benzoxazines
  • HIV Protease Inhibitors
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • efavirenz